Unicycive Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Unicycive Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- UNCY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001766140
Board of directors
-
Brigitte Schiller · DirectorSince 2023
-
Gaurav Aggarwal · DirectorSince 2023
-
John L. Ryan · DirectorSince 2023
-
Sandeep Laumas · DirectorSince 2023
-
Sara Kenkare-Mitra · DirectorSince 2023
-
Shalabh K. Gupta · Director · CEOSince 2023
Chief executives
Shalabh K. Gupta
· CEO
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Gaurav Aggarwal
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 25, 2025 | Gaurav Aggarwal Director | Derivative conversion | +652,900 | — | — |
| Feb 18, 2025 | Gaurav Aggarwal Director | Derivative conversion | +1,400,000 | — | — |
| Oct 9, 2024 | Gaurav Aggarwal Director | Derivative conversion | +5,500,000 | — | — |
| Jul 11, 2023 | Gaurav Aggarwal Director | Derivative conversion | +3,470,152 | — | — |
| Jul 11, 2023 | Jermasek Douglas Officer (EVP of Corporate Strategy) | Option exercise | +104,612 | — | — |
| Jul 11, 2023 | Gupta Pramod Officer (EVP, Pharmaceuticals and BD) | Option exercise | +41,845 | — | — |
| Jul 11, 2023 | Shalabh K. Gupta Director, Officer (CEO) | Option exercise | +104,612 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.